Global Neuroendocrine Carcinoma Treatment Market Size, Share, and COVID-19 Impact Analysis, By Indication Type (Gastric Neuroendocrine Tumor, Lung Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, and Appendiceal Neuroendocrine Tumors), By Treatment Type (Chemotherapy, Antimetabolites, Alkylating agents, Natural Products, Targeted Therapy, Tyrosine Kinase Inhibitor, mTOR Inhibitor, and Somatostatin Analogs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
$5550
Total
$5550
Need assistance?
Call us or write to us:
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies